FDA Inspection 1021764 — Joseph F. Fowler, Jr., M.D.

Joseph F. Fowler, Jr., M.D. — FEI 3001194048

The FDA completed an inspection of Joseph F. Fowler, Jr., M.D. on August 16, 2017 in Louisville, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 16, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Louisville, KY (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
749821 CFR 312.66Unanticipated problems
752621 CFR 312.62(a)Accountability records
756021 CFR 312.60FD-1572, protocol compliance